Mergers & Acquisitions

  • September 28, 2026

    SEC Says Couple Leaked Info Ahead Of $3.7B Cummins Deal

    The U.S. Securities and Exchange Commission announced settlements Monday with a former Cummins Inc. manager and her husband charged with disclosing details about the company's $3.7 billion Meritor acquisition to a chain of individuals who reaped over $500,000 from the inside information.

  • September 28, 2026

    3 Firms Lead $663.7M Lifecore Biomedical Take-Private Deal

    Lifecore Biomedical Inc. on Monday unveiled plans to become a private company after it is bought by private equity shop Webster Equity Partners in a deal valued at up to $663.7 million that was built by three law firms.

  • September 28, 2026

    Nextdoor, Khosla Say Investor Brought De-SPAC Suit Too Late

    Nextdoor and Khosla Ventures urged the Delaware Chancery Court on Monday to dismiss a stockholder lawsuit challenging Nextdoor's de-SPAC merger as untimely, arguing the clock began running when the proxy that an investor described as misleading was issued in October 2021, while the plaintiff insisted later disclosures and tolling doctrines keep her claims alive.

  • September 28, 2026

    Lantheus Investor Asks Court To Halt 'Unfair' $8B Curium Deal

    A Lantheus Holdings Inc. investor wants a Massachusetts state judge to block its $8 billion take-private deal with fellow radiopharmaceutical company Curium in its current form, calling the deal "fundamentally unfair" to shareholders.

  • September 28, 2026

    Del. High Court Adds To Vet Patent Indemnity, Strikes Interest

    The Delaware Supreme Court has issued a mixed ruling in a veterinary implant patent dispute, holding a company's founder liable for his share of a $9.8 million license and about $2.4 million more in defense fees while striking millions in prejudgment interest he had been ordered to pay.

  • September 28, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week heard arguments over whether to dismiss a derivative suit accusing UiPath Inc. insiders of misleading investors and trading on inside information, while a Match Group Inc. stockholder sued for records concerning reports of sexual assault and other violence involving users of the company's dating apps.

  • September 28, 2026

    Broadfield, Loeb Guide $587M Aerospace SPAC Deal

    Aerospace and defense company Astro Digital US, advised by Broadfield LLP, on Monday announced plans to go public by merging with Loeb & Loeb LLP-led special purpose acquisition company Proem Acquisition Corp I in a deal that values it at a pro forma post-money enterprise value of roughly $587 million.

  • September 28, 2026

    Wachtell, Sidley Advise On Valley Bank's $340M Bluevine Deal

    Valley National Bancorp said Monday it has agreed to acquire digital banking platform Bluevine for about $340 million, expanding the regional bank's small business franchise and adding a nationwide digital deposit channel.

  • September 28, 2026

    Brixmor, Everview Team Up On $2.34B Grocery REIT Buy

    Brixmor Property Group and private investment firm Everview Partners have agreed to acquire Canadian-listed Slate Grocery REIT in a transaction valued at about $2.34 billion, the companies said Monday, with at least seven law firms advising on the deal.

  • September 28, 2026

    Holland & Knight Adds Partner In Atlanta From McDermott

    A former McDermott Will & Schulte attorney has joined Holland & Knight LLP's corporate, mergers and acquisitions and securities section as a partner in Atlanta, Holland & Knight announced Monday.

  • September 28, 2026

    Kirkland, White & Case Lead Defense Firm's $1.25B SPAC Deal

    REDLattice and blank check company Bold Eagle Acquisition Corp. said Monday they have agreed to merge in a deal that would take the cyber intelligence company public at a $1.25 billion premoney enterprise value.

  • September 28, 2026

    SocGen, Vodafone Get EU Approval For German Fiber Co. Buy

    The European Commission said Monday it has cleared banking giant Société Générale and telecoms company Vodafone GmbH's plan to jointly own German fiber network OXG Glasfaser.

  • September 28, 2026

    Norway's DNO Won't Raise $396M Bid For Scottish Energy Biz

    Norwegian oil and gas firm DNO ASA said Monday it will not increase its $396 million bid for Scottish firm Capricorn, paving the way for rival bidder Genel Energy PLC to forge ahead with its $436 million deal.

  • September 28, 2026

    CVC Ends Bodycote Pursuit As Veritas' £1.85B Offer Accepted

    CVC said Monday that it will not go ahead with its proposed takeover of Bodycote after the thermal-processing company's board backed a rival £1.85 billion ($2.5 billion) offer from Veritas.

  • September 25, 2026

    F9 Sues Bed Bath & Beyond's Owner Over Canceled Deal

    The owner of Bed Bath & Beyond was sued Friday in Delaware Chancery Court by the owners of Cabinets To Go and Lumber Liquidators, who say the company publicly mischaracterized the collapse of a proposed acquisition and then used confidential due diligence materials to compete against them in the flooring and kitchen markets.

  • September 25, 2026

    SEC Says Mich. Atty Tipped Family About Pharma Co. Merger

    The U.S. Securities and Exchange Commission on Friday accused a Michigan tax lawyer of insider trading, alleging he told his brother and cousin about a planned but not-yet-announced merger between Y-mAbs Therapeutics Inc. and SERB Pharmaceuticals.

  • September 25, 2026

    Texas Judge Says Perot's VC Firm Can't Be Held To Handshake

    The Texas Business Court threw out a lawsuit brought by a Dallas businessman accusing billionaire Ross Perot Jr. of stiffing him out of his rightful equity interest in a healthcare company that sold for $2 billion, saying the businessman signed an agreement waiving his interest in the company.

  • September 25, 2026

    'Experience Drain' Leaves FTC, DOJ Staffers More Hesitant

    Months before he left the U.S. Department of Justice's Antitrust Division, the agency's chief said that prospective job seekers no longer needed the substantial profile previously required to work for the agency, a change he cast as a positive for young attorneys.

  • September 25, 2026

    Detractors Tell Court Paramount Deal Fails To Fix Concerns

    Civil rights and public interest groups have told a California federal court the settlement ending a challenge of Paramount Skydance's purchase of Warner Bros. Discovery fails to address the concerns state enforcers raised in the first place.

  • September 25, 2026

    Tariffs, Not Fraud, Hurt Apparel Co.'s Finances, Court Told

    Protective apparel company Lakeland Industries Inc. asked a New York federal court to dismiss a proposed investor class action accusing it of ignoring a former finance employee's concerns about its global sales data and concealing information about its true financial condition, saying missing earnings estimates is "unfortunate" but not fraud.

  • September 25, 2026

    K&L Gates Adds Townsend SALT Partner In New York

    K&L Gates LLP added to its New York office a new corporate tax partner who specializes in complex tax planning and controversy, the firm announced.

  • September 25, 2026

    UK CMA Raises Concerns Over Macquarie Energy Meters Deal

    United Kingdom antitrust officials threatened Friday to launch an in-depth probe into Macquarie Asset Management's planned purchase of the country's largest analog gas metering service company for commercial customers, unless they address concerns about overlap with another gas metering company in which Macquarie has a controlling interest.

  • September 25, 2026

    Dublin Power Co. Eaton Buying Italy's COL In €810M Deal

    Dublin-based power management company Eaton said Friday it has agreed to purchase Italian electric company COL Group from Oaktree Capital Management for an enterprise value of €810 million ($923 million).

  • September 25, 2026

    Novo Bets $1.3B On Nanexa Drug Tech Amid Obesity Push

    Novo Nordisk has agreed to pay up to about €1.165 billion ($1.3 billion) under an exclusive license and collaboration agreement for Swedish drug-delivery company Nanexa's PharmaShell technology.

  • September 25, 2026

    Don't Miss It: Simpson Thacher, Latham Steer Hot Deals

    A lot can happen in the world of mergers and acquisitions and equity fundraising over the course of a couple of weeks, and it's difficult to keep up with all the deals. Here, Law360 recaps the ones you may have missed, including transactions helmed by Simpson Thacher & Bartlett LLP and Latham & Watkins LLP.

Expert Analysis

  • Navigating OFAC's 50% Rule For Cross-Border Exec Mobility

    Author Photo

    A recent Office of Foreign Assets Control guide signals that its 50% ownership rule can determine not only sanctions compliance but also whether a company can sponsor multinational executives for immigration, highlighting an often overlooked interaction between sanctions and immigration law, says Xuan Zhang at Reid & Wise.

  • What PE Practitioners Need To Know About New Del. ABC Act

    Author Photo

    Delaware's new Assignment for the Benefit of Creditors statute represents a structural shift in how companies backed by private equity can be wound down and provides a more streamlined tool for managing sponsor liability without the public visibility of a bankruptcy proceeding, says Evelyn Meltzer at Troutman Pepper.

  • Series

    Being A Magician Makes Me A Better Lawyer

    Author Photo

    The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

  • Illinois Audit Law Will Make AI Clauses Actually Enforceable

    Author Photo

    A law recently enacted in Illinois creates a first-in-the-nation requirement for artificial intelligence developers to undergo annual audits, providing objective standards that can be incorporated into private contracts and addressing the problem of defining responsible AI use, says William Tanenbaum at Moses & Singer.

  • Fiduciary Duty Risks In Continuation Vehicle Transactions

    Author Photo

    Continuation vehicle transactions have become prominent in private equity, but conflicts may arise due to transaction structures and implicate fiduciary duties, with a recent Delaware case highlighting several procedural considerations for sponsors, say attorneys at Debevoise.

  • A New Regulatory Environment For PE In Calif. Healthcare

    Author Photo

    The California Office of Health Care Affordability's proposed revisions to its cost and market impact review regulations, amid broader state scrutiny of private equity-backed healthcare arrangements, represent a qualitative shift in California's regulatory posture toward institutional healthcare investment, say attorneys at Ropes & Gray.

  • CFIUS' Mandate Misses Foreign Risk In Project Subcontracts

    Author Photo

    Recent calls for the Committee on Foreign Investment in the United States to review equity transactions like the Paramount Skydance-Warner Bros. deal miss a consequential oversight gap — CFIUS' inability to review the subcontracting layer of U.S. infrastructure projects, says Thibaut Giret at Alstef Group.

  • Series

    Bass Fishing Makes Me A Better Lawyer

    Author Photo

    Landing a trophy striped bass and closing a big deal both require cultivating the patience to finesse — not force — your way to desired outcomes, changing course when your old approach isn’t working and learning from the ones that got away, says Jon Ruiss at Alston & Bird.

  • What Consent Decree Trends Mean For Deal Clearances

    Author Photo

    With merger remedies back on the table under the current administration, an analysis of recent Federal Trade Commission and U.S. Department of Justice consent decrees reveals that prior approval and prior notice provisions are no longer a foregone conclusion, and companies may be able to negotiate narrowly tailored obligations, say attorneys at Weil.

  • How Reincorporating In Texas May Alter Earnout Disputes

    Author Photo

    While the DExit debate has focused on shareholder suits, far less attention has been paid to what reincorporating in Texas means for M&A disputes, making it particularly important to understand the nuances between Delaware and Texas earnout jurisprudence, say attorneys at Selendy Gay.

  • Roundup

    The Most Talked-About Supreme Court Decisions Of 2026

    Author Photo

    This term, 11 U.S. Supreme Court decisions quickly became hot topics among Law360's guest writers.

  • Structuring Space Nuclear Deals For Regulatory Risk

    Author Photo

    With the White House's recent focus on space nuclear power, a highly important question for companies that want to build orbital reactors, lunar surface systems or critical components is whether the transaction documents can handle foreign investment constraints, export controls and treaty-linked liability, says Kristie Blase at Frazer + Blase.

  • Texas Business Court Rulings Show Deal Terms Paramount

    Author Photo

    As the courts within the Texas Business Court system have begun reaching the substantive merits of the cases before them, they are persuasively demonstrating they will not only enforce the terms of transactions as written, but will also embrace a holistic approach to complex transaction documentation interpretation, says Christopher Pace at Winston Taylor.

  • Quantum Readiness May Paradoxically Raise Contractor Risk

    Author Photo

    The organizations best positioned for the cryptographic system migration deadlines and other requirements under President Donald Trump’s recent quantum executive orders will be those able to inventory their cryptographic dependencies while protecting their vulnerability road map from adversaries, says Jesse Lemon at The Beckage Firm.

  • Why Biotech Cos. Need Litigation Plans Before Bad News

    Author Photo

    Biotech companies should take proactive steps to respond to the growing trend of securities litigation filed against them, due to the inherently uncertain nature of their business models and heightened scrutiny of clinical trial disclosures, regulatory communications and investor-facing statements, says Wesley Horton at FBFK.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.